An infection control products manufacturer has announced the appointment of a new chief financial officer.
Tristel, based in Snailwell, Newmarket, revealed that Anna Wasyl will take on the role from September 1, replacing Liz Dixon.
Ms Wasyl has a wealth of experience, with a background in technology-driven industries, specifically medical devices, robotics, and industrial automation.
She has spent more than 20 years working for publicly listed and venture-backed companies.
She joins Tristel from Cambridge-based CMR Surgical, where she held senior roles, leading a significant turnaround programme.
Ms Wasyl said: "I am honoured to join Tristel as its new chief financial officer.
"Tristel has established a well-earned reputation for innovation and leadership in infection prevention, and I look forward to being CFO for this exceptional business.
"Together, we will continue to focus on delivering growth and exceptional value to our customers and stakeholders."
Bruno Holthof, chair of Tristel, said: "We are very pleased Anna is joining as our new CFO.
"She brings a strong track record of driving sustainable growth and scaling up operations."
Share